Skip to content
Bdenza

BDR Pharmaceutical Int’l Pvt. Ltd.

Bdenza


“Bdenza” contains Drug / Molecule called “Enzalutamide”. Enzalutamide is a Non-steroidal Antiandrogen (NSAA) medication which is used in the treatment of Prostate Cancer.


Indication

Bdenza is indicated for use in conjunction with castration in the treatment of Metastatic castration-resistant Prostate Cancer, Non-metastatic castration-resistant Prostate Cancer and Metastatic castration-sensitive Prostate Cancer.

Bdenza can be used as an antiandrogen in feminizing hormone therapy for transgender women.

Note

SIDE EFFECTS :

  • Side effects of Bdenza include Gynecomastia, Breast pain / tenderness, fatigue, Diarrhea, Hot flashes, Headache, Sexual dysfunction and less commonly seizures.
  • Other Common side effects included Neutropenia, Visual hallucination, anxiety, dry skin and itching.

INTERACTIONS :

  • Bdenza is a moderate to strong inducer of multiple Cytochrome P450 enzymes including CYP3A4, CYP2C9 and CYP2C19 and hence has a high potential for clinically relevant Drug Interactions
  • Circulating concentrations of Bdenza may be altered by Inhibitors and Inducers of CYP2C8 and CYP3A4, and should be avoided if possible.
  • In a clinical study of Bdenza for ER-positive Breast cancer in women, Bdenza was found to decrease serum concentrations of the Aromatase Inhibitors Anastrozole and Exemestane by 90% and 50%, respectively, which could reduce their effectiveness.

OVERDOSE :

  • Do not use more than prescribed dose.
  • Patients who have received doses higher than those recommended should be carefully monitored.
  • Do not take extra dose to make up for the missed dose.
  • Bdenza may cause seizures if Overdosed.

 

Precaution

  • Bdenza is a prescription drug and should be used under proper medical guidance and advice.
  • Bdenza is contraindicated in women during Pregnancy. It may cause fetal harm.
  • Advice patient to avoid breast feeding during and for 3 months following completion of therapy.

 

 

Updated On Nov 11, 2020 by Admin

Strength

40 mg

Packing

1 X 28 Capsules (Strip)

Storage

Store at room temperature.



Related Products


CIPLA LTD. (INDIA)

Cassotide

JANSEEN PHARMACEUTICAL CO.

Zytiga-xbira

CIPLA LTD.

Zecyte

CIPLA LTD. (INDIA)

Xbira


Most Viewed Products


CIPLA LTD. (INDIA)

Abiraterone acetate-xbira

NATCO PHARMA LIMITED (INDIA)

Bendamustine-bendit

CIPLA LTD. (INDIA)

Bicalutamide-cassotide

NATCO PHARMA LIMITED (INDIA)

Bortezomib-bortenat

NATCO PHARMA LIMITED (INDIA)

Erlonat

Biocon Limited

Everolimus-evertor

NATCO PHARMA LIMITED (INDIA)

Exemestane-xtane

NATCO PHARMA LIMITED (INDIA)

Geftinat

NATCO PHARMA LIMITED (INDIA)

Glatiramer acetate-glatimer

NATCO PHARMA LIMITED (INDIA)

Ledipasvir & sofosbuvir-hepcinat lp

NATCO PHARMA LIMITED (INDIA)

Lenalidomide-lenalid

NATCO PHARMA LIMITED (INDIA)

Pomalidomide-pomalid

NATCO PHARMA LIMITED (INDIA)

Sofosbuvir & velpatasvir-velpanat

NATCO PHARMA LIMITED (INDIA)

Sorafenib-sorafenat

CIPLA LTD. (INDIA)

Tenofovir-tenvir

Top Products

Lenvatinib  | Sunishil

Sunitinib-Sutinat

Sunitinib-Sutinat

Quick Query

Direct to your Phone